Pharmafile Logo
Pharmafocus logo
Advanced Search
394px-ad_versus_co

New model can help predict cognitive decline in patients with Alzheimer’s

August 5, 2019
Sales and Marketing Alzheimer's pharma, cognitive decline, computing, dementia, pharma

Scientists at MIT have developed a new model which can predict whether patients at risk for Alzheimer’s disease will experience …

News

Pollen spores could be used to protect potent, ocean-dwelling antibiotics in fighting antibiotic resistant superbugs

August 5, 2019
Research and Development, Sales and Marketing AMR, Antibiotics, MRSA, club moss, pharma, pollen, spores

Spores from a plant called the common club moss (Lycopodium clavatum) could be used to protect light-sensitive antibiotics, that are …

News
index_ph001

Daiichi Sankyo’s Turalio becomes first FDA-approved therapy for rare tumour

August 5, 2019
Sales and Marketing Cancer, Daiichi Sankyo, FDA, Turalio, US, pharma, rare cancer

Daiichi Sankyo has seen its CSF1R inhibitor Turalio (pexidartinib) approved by the FDA in the treatment of symptomatic tenosynovial giant …

News

Roche’s Tecentriq meets primary endpoint in Phase 3 bladder cancer trial

August 5, 2019
Sales and Marketing Cancer, Roche, bladder cancer, immunotherapy, oncology, tecentriq

Roche has said its immunotherapy drug Tecentriq (Atezolizumab), when used in combination with platinum-based chemotherapy, significantly reduced the risk of …

News
shutterstock_141299494

Top UK doctors warn Boris Johnson that no-deal Brexit would cause key cancer therapy supply shortages

August 2, 2019
Manufacturing and Production, Medical Communications Cancer, NHS, UK, brexit, pharma

Top doctors from some of the UK’s foremost nuclear medicine associations have written a letter to recently-anointed Prime Minister Boris …

News
dr_wajid_hussain

Dr Wajid Hussain appointed new clinical director for digital health at RCP

August 2, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing IT, RCP, Royal College of Physicians, digital health, pharma

The Royal College of Physicians (RCP) has appointed Dr Wajid Hussain as its new clinical director for digital health. Dr …

Appointment
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

August 2, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Pfizer dominated the headlines this week as the US firm closed its $9.8 billion merger with GSK and announced that …

News

AI accurately detects subtle signs of atrial fibrillation even in normal tests

August 2, 2019
Medical Communications AF, AI, ECG, atrial fibrillation, electrcardiogram, pharma

A new study from the Mayo Clinic shows that artificial intelligence (AI) can detect signs of atrial fibrillation (AF) in …

News
nucala-web

European approval for two new delivery formulations of GSK’s Nucala in severe eosinophilic asthma

August 2, 2019
Medical Communications, Sales and Marketing Europe, GSK, Nucala, asthma, pharma

Following closely on the heels of the news that its deal to merge Pfizer’s consumer health business with its own, …

News
image_credit_gage_skidmore

US presidential candidate Bernie Sanders pledges to allow Americans to import drugs from Canada

August 2, 2019
Medical Communications Bernie Sanders, Canada, Trump, US, democrats, prescription drugs

Democratic presidential candidate Bernie Sanders has said he will, on his first day in office, allow for the importation of …

News
shutterstock_512649

Janssen returns rights for experimental cancer immunotherapy to Alligator Bioscience, sending shares spiraling by 40%

August 1, 2019
Sales and Marketing Alligator Bioscience, Janssen, pahrma

Janssen has decided to hand back the rights to an experimental CD40 agonistic antibody to Alligator Bioscience as it reassesses …

News
novartis_outside_1

Novartis’ Kisqali reinforces overall survival benefit in postmenopausal HR+/HER2- breast cancer

August 1, 2019
Research and Development Cancer, Kisqali, Novartis, breast cancer, pharma

New Phase 3 evidence has emerged on the efficacy of Novartis’ Kisqali (ribociclib) in combination with AstraZeneca’s Faslodex (fulvestrant) in …

News
shutterstock_273326141

GSK closes the deal with Pfizer over $9.8 billion consumer healthcare merger

August 1, 2019
Sales and Marketing GSK, Pfizer, merger, pharma

The $9.8 billion joint venture between major pharma firms GlaxoSmithKline and Pfizer to merge their consumer health operations has come …

News

Bayer’s Xarelto combo greenlighted by NICE for reducing CV events in artery disease

August 1, 2019
Sales and Marketing NHS, NICE, UK, Xarelto, cardiovascular disease, pharma

NICE has awarded final appraisal recommendation to Bayer’s Xarelto (rivaroxaban) at a dosage of 2.5mg twice daily in combination with …

News

FDA steps up 2018 drug approvals by 11% on previous year

August 1, 2019
Sales and Marketing EMA, FDA, drug approvals, pharma

The FDA continues to excel in the ground it covers as it emerges that the total number of new drug …

News
merckentranceweb

MSD to bring over 400 new jobs to North Carolina with two site expansions

July 31, 2019
Manufacturing and Production, Research and Development MSD, US, pharma

MSD has announced a $650 million expansion of its existing facilities in North Carolina – a move which is bring …

News
shutterstock_212432119

Biogen & Alkermes’ multiple sclerosis drug proves “statistically superior” to Tecfidera at Phase 3

July 31, 2019
Research and Development Alkermes, Biogen, multiple sclerosis, pharma

Biogen and Alkermes have unveiled new Phase 3 data for diroximel fumarate, comparing the adequacy of the therapy to Biogen’s …

News
lilly_entrance_web

Lilly’s Verzenio combo shows additional breast cancer survival benefit in new Phase 3 data

July 31, 2019
Research and Development Cancer, Eli Lilly, Verzenio, breast cancer, pharma

Eli Lilly has revealed new Phase 3 data on its CDK4 & 6 inhibitor Verzenio (abemaciclib), demonstrating its efficacy in …

News
fda2outsideweb

Bayer and Orion’s Nubeqa secures FDA approval in non-metastatic castration-resistant prostate cancer

July 31, 2019
Research and Development, Sales and Marketing Bayer, Cancer, Nubeqa, orion, pharma, prostate cancer

The FDA has awarded approval under its Priority Review pathway to Nubeqa (darolutamide) for the treatment of non-metastatic castration-resistant prostate …

News
bacteria-163711_960_720

Cigarette smoke causes superbug to become more drug resistant, study shows

July 30, 2019
Research and Development AMR, MRSA, cigarettes smoke, drug resistance, pharma, smoking

Cigarette smoke can make certain strains of the bacteria Methicillin-resistant Staphylococcus aureus (MRSA) more resistant to antibiotics, according to a …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026